ARWR
ARWR
NASDAQ · Biotechnology

Arrowhead Pharmaceuticals In

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$60.77
+4.50 (+8.00%)
As of Mar 25, 9:46 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 15 79%
Hold 4 21%
Sell 0 0%
Price Target
Analyst Price Target +14.4% upside
Low Target $62.98
Average Target $69.50
High Target $88.85
Current Price $60.77
Current
$60.77
Target
$69.50
$62.98 $69.50 avg $88.85
Scenario Analysis
Bear Case
$62.98
3.6%
Low target
Base Case
$69.50
+14.4%
Avg target
Bull Case
$88.85
+46.2%
High target
Risk/Reward
12.7x
Highly favorable
Price in Context
52-Week High
$76.76
-20.8% from high
52-Week Low
$9.57
+535.0% from low
50-Day SMA
$66.84
-9.1% vs SMA
200-Day SMA
$36.65
+65.8% vs SMA
RSI (14)
36.5
Neutral
Target vs 52W High
$69.50
-9.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%